Related Experiment Video
Updated: Feb 13, 2026

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
Published on: May 19, 2020
IGF-1 receptor cleavage in hypertension
Selma Cirrik1, Geert W Schmid-Schönbein2
1Department of Physiology, Faculty of Medicine, Ordu University, Ordu, Turkey. selmacrrk@yahoo.com.
Hypertension increases protease activity, leading to insulin-like growth factor-1 receptor (IGF-1R) cleavage and reduced IGF-1 response. Matrix metalloproteinase (MMP) inhibition prevented this cleavage in spontaneously hypertensive rats.
Area of Science:
- Cardiovascular Biology
- Protease Biochemistry
- Endocrinology
Background:
- Hypertension is linked to impaired insulin-like growth factor-1 (IGF-1) signaling.
- Increased protease activity in hypertension can cause extracellular receptor cleavage, leading to dysfunction.
Purpose of the Study:
- To investigate the association between enhanced protease activity and IGF-1 receptor (IGF-1R) cleavage in spontaneously hypertensive rats (SHRs).
- To determine the impact of matrix metalloproteinase (MMP) activity on IGF-1R function in the aorta.
Main Methods:
- Compared MMP activity in plasma and tissues of SHRs and Wistar Kyoto (WKY) rats using gelatin zymography.
- Incubated WKY aorta rings with SHR plasma, with and without MMP inhibitors, assessing IGF-1R subunit density via immunohistochemistry.
- Analyzed downstream signaling (pAkt, peNOS) using immunoblotting to evaluate IGF-1R function.
Main Results:
- SHRs exhibited increased plasma and tissue MMP-2 and MMP-9 activity.
- SHR plasma reduced IGF-1R alpha subunit density in WKY aorta endothelium, an effect prevented by MMP inhibitors.
- SHRs showed lower pAkt and peNOS levels, indicating impaired IGF-1 signaling in the aorta.
Conclusions:
- Elevated MMP activity in hypertension contributes to IGF-1R alpha subunit cleavage.
- MMP-dependent IGF-1R cleavage impairs IGF-1 cellular response in the aorta of spontaneously hypertensive rats.
Related Concept Videos
Cleavage and Blastulation
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension I: Introduction

